Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study
European Journal of Cancer2016Vol. 65, pp. 91–101
Citations Over TimeTop 1% of 2016 papers
Barbara C. Worst, Cornelis M. van Tilburg, Gnana Prakash Balasubramanian, Petra Fiesel, Ruth Witt, Angelika Freitag, Miream Boudalil, Christopher Previti, Stephan Wolf, Sabine Schmidt, Sasithorn Chotewutmontri, Melanie Bewerunge‐Hudler, Matthias Schick, Matthias Schlesner, Barbara Hutter, Lenka A. Taylor, Tobias Borst, Christian Sutter, Claus R. Bartram, Till Milde, Elke Pfaff, Andreas E. Kulozik, Arend von Stackelberg, Roland Meisel, Arndt Borkhardt, Dirk Reinhardt, Jan‐Henning Klusmann, Gudrun Fleischhack, Stephan Tippelt, Uta Dirksen, Heribert Jürgens, Christof M. Kramm, André O. von Bueren, Frank Westermann, Matthias Fischer, Birgit Burkhardt, Wilhelm Wößmann, Michaela Nathrath, Stefan Bielack, Michael C. Frühwald, Simone Fulda, Thomas Klingebiel, Ewa Kościelniak, Matthias Schwab, Roman Tremmel, Pablo Hernáiz Driever, Johannes H. Schulte, Benedikt Brors, Andreas von Deimling, Peter Lichter, Angelika Eggert, David Capper, Stefan M. Pfister, David Jones, Olaf Witt
Related Papers
- → Structure-based assessment and druggability classification of protein–protein interaction sites(2022)41 cited
- → Druggability of the enzymes of the non-mevalonate-pathway(2013)61 cited
- → Druggability analysis and classification of protein tyrosine phosphatase active sites(2016)51 cited
- → Network motifs modulate druggability of cellular targets(2016)13 cited
- → Druggability Prediction(2012)5 cited